Nutra Pharma Corp (NPHC) Revenue (2010 - 2026)

Nutra Pharma has disclosed Revenue across 17 years of filings, most recently posting $34463.0 for Q2 2026.

• In Q2 2026, Revenue fell 59.23% year-over-year to $34463.0; the TTM figure through Jun 2026 stood at $160815.0 (down 49.01% YoY), while the FY2025 annual figure was $257612.0, up 4.59% from the prior year.
• Revenue came in at $34463.0 for Q2 2026 at Nutra Pharma, up from $27246.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $84532.0 in Q2 2025 to a low of $13759.0 in Q1 2022.
• Average Revenue over 5 years is $50944.1, with a median of $51661.0 recorded in 2023.
• Year-over-year, Revenue soared 296.26% in 2023 and tumbled 64.75% in 2025.
• Over 5 years, Revenue stood at $78986.0 in 2022, then slumped by 40.46% to $47032.0 in 2023, then soared by 74.08% to $81873.0 in 2024, then sank by 64.75% to $28864.0 in 2025, then advanced by 19.4% to $34463.0 in 2026.
• Per Business Quant data, the three most recent Revenue figures were $34463.0 in Q2 2026, $27246.0 in Q1 2026, and $28864.0 in Q4 2025.